Invesco Ltd. Sells 853,208 Shares of Hims & Hers Health, Inc. $HIMS

Key Points

• Invesco Ltd. has significantly reduced its stake in Hims & Hers Health by 66.8%, selling 853,208 shares in the first quarter and now owning 423,818 shares valued at approximately $12.5 million.
• Various institutions have altered their holdings in Hims & Hers Health, with UMB Bank raising its position by 247.5%, while institutional investors currently own 63.52% of the stock.
• The latest earnings report showed a miss on EPS estimates, with Hims & Hers Health reporting $0.17 EPS against the consensus estimate of $0.18, despite a 72.6% year-over-year revenue increase.

Invesco Ltd. trimmed its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 66.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 423,818 shares of the company's stock after selling 853,208 shares during the quarter. Invesco Ltd. owned 0.19% of Hims & Hers Health worth $12,524,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in HIMS. UMB Bank n.a. raised its position in Hims & Hers Health by 247.5% in the first quarter. UMB Bank n.a. now owns 1,310 shares of the company's stock worth $39,000 after acquiring an additional 933 shares during the period. Larson Financial Group LLC raised its position in shares of Hims & Hers Health by 47.7% during the first quarter. Larson Financial Group LLC now owns 1,419 shares of the company's stock valued at $42,000 after buying an additional 458 shares during the last quarter. Fifth Third Bancorp increased its holdings in shares of Hims & Hers Health by 165.4% in the first quarter. Fifth Third Bancorp now owns 1,542 shares of the company's stock worth $46,000 after purchasing an additional 961 shares during the last quarter. Tsfg LLC bought a new stake in shares of Hims & Hers Health in the first quarter worth about $46,000. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of Hims & Hers Health in the first quarter worth about $49,000. 63.52% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on HIMS. UBS Group set a $30.00 target price on shares of Hims & Hers Health in a report on Monday, June 23rd. Morgan Stanley reiterated an "equal weight" rating and set a $40.00 price objective on shares of Hims & Hers Health in a research report on Wednesday, June 11th. TD Cowen downgraded Hims & Hers Health from a "buy" rating to a "hold" rating and cut their price objective for the company from $44.00 to $30.00 in a research report on Tuesday, April 29th. Wall Street Zen downgraded Hims & Hers Health from a "buy" rating to a "hold" rating in a research report on Monday, July 28th. Finally, Bank of America upped their price objective on Hims & Hers Health from $22.00 to $26.00 and gave the company an "underperform" rating in a research report on Tuesday, April 29th. Two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Hims & Hers Health presently has a consensus rating of "Reduce" and a consensus target price of $38.92.

Insider Transactions at Hims & Hers Health

In other Hims & Hers Health news, insider Patrick Harrison Carroll sold 60,000 shares of Hims & Hers Health stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $53.58, for a total transaction of $3,214,800.00. Following the completion of the sale, the insider owned 169,940 shares of the company's stock, valued at approximately $9,105,385.20. The trade was a 26.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael Chi sold 2,100 shares of Hims & Hers Health stock in a transaction dated Thursday, July 24th. The stock was sold at an average price of $57.52, for a total value of $120,792.00. Following the sale, the insider directly owned 278,654 shares of the company's stock, valued at approximately $16,028,178.08. This represents a 0.75% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,396,090 shares of company stock worth $71,927,627. 13.71% of the stock is owned by insiders.

Hims & Hers Health Stock Up 1.3%

NYSE:HIMS opened at $44.53 on Friday. Hims & Hers Health, Inc. has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The stock has a market capitalization of $10.06 billion, a P/E ratio of 55.66, a P/E/G ratio of 3.01 and a beta of 2.08. The company has a debt-to-equity ratio of 1.72, a quick ratio of 4.46 and a current ratio of 4.98. The company's 50-day simple moving average is $51.71 and its 200-day simple moving average is $45.81.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The business had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.Hims & Hers Health's revenue was up 72.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.06 EPS. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.